160 related articles for article (PubMed ID: 36634283)
21. [Mucositis after allogeneic stem cell transplantation: Risk factors, clinical consequences and prophylaxis].
Bourdelin M; Daguindau E; Larosa F; Legrand F; Nerich V; Deconinck E; Limat S
Pathol Biol (Paris); 2015 Apr; 63(2):106-10. PubMed ID: 25555496
[TBL] [Abstract][Full Text] [Related]
22. Oral mucositis-related oropharyngeal pain and correlative tumor necrosis factor-alpha expression in adult oncology patients undergoing hematopoietic stem cell transplantation.
Fall-Dickson JM; Ramsay ES; Castro K; Woltz P; Sportés C
Clin Ther; 2007; 29 Suppl():2547-61. PubMed ID: 18164921
[TBL] [Abstract][Full Text] [Related]
23. The incidence of severe oral mucositis in patients undergoing different conditioning regimens in haematopoietic stem cell transplantation.
Nakagaki M; Kennedy GA; Gavin NC; Clavarino A; Whitfield K
Support Care Cancer; 2022 Nov; 30(11):9141-9149. PubMed ID: 36008731
[TBL] [Abstract][Full Text] [Related]
24. Access to oral care before hematopoietic stem cell transplantation: understand to improve.
Nuernberg MA; Nabhan SK; Bonfim CM; Funke VA; Torres-Pereira CC
Support Care Cancer; 2016 Aug; 24(8):3307-13. PubMed ID: 26951151
[TBL] [Abstract][Full Text] [Related]
25. Oral health in patients scheduled for hematopoietic stem cell transplantation in the Orastem study.
Skallsjö K; von Bültzingslöwen I; Hasséus B; Johansson JE; Öhman J; Raber-Durlacher JE; Huysmans MDNJM; Laheij AMGA; van Leeuwen SJM; Hovan AJ; Garming Legert K; Nguyen HM; Turk PJ; Rozema FR; Blijlevens NMA; Brennan MT
PLoS One; 2023; 18(5):e0285615. PubMed ID: 37200298
[TBL] [Abstract][Full Text] [Related]
26. Cost-effectiveness of the introduction of specialized oral care with laser therapy in hematopoietic stem cell transplantation.
Bezinelli LM; de Paula Eduardo F; da Graça Lopes RM; Biazevic MG; de Paula Eduardo C; Correa L; Hamerschlak N; Michel-Crosato E
Hematol Oncol; 2014 Mar; 32(1):31-9. PubMed ID: 23625880
[TBL] [Abstract][Full Text] [Related]
27. Oral complications in hematopoietic stem cell recipients: the role of inflammation.
Haverman TM; Raber-Durlacher JE; Rademacher WM; Vokurka S; Epstein JB; Huisman C; Hazenberg MD; de Soet JJ; de Lange J; Rozema FR
Mediators Inflamm; 2014; 2014():378281. PubMed ID: 24817792
[TBL] [Abstract][Full Text] [Related]
28. Dental consensus on HSCT - Part II: dental Care during HSCT.
Gobbi MF; Ferreira MH; de Carvalho DLC; Silva GBL; Macari KSM; Neves LJ; Santos PSDS; Junior LAVS; Melo WR; Antunes HS; De Macedo LD; Eduardo FP; Bezinelli LM
Hematol Transfus Cell Ther; 2023; 45(3):368-378. PubMed ID: 37321878
[TBL] [Abstract][Full Text] [Related]
29. Third-Party and Patient-Specific Donor-Derived Virus-Specific T Cells Demonstrate Similar Efficacy and Safety for Management of Viral Infections after Hematopoietic Stem Cell Transplantation in Children and Young Adults.
Galletta TJ; Lane A; Lutzko C; Leemhuis T; Cancelas JA; Khoury R; Wang YM; Hanley PJ; Keller MD; Bollard CM; Davies SM; Grimley MS; Rubinstein JD
Transplant Cell Ther; 2023 May; 29(5):305-310. PubMed ID: 36736781
[TBL] [Abstract][Full Text] [Related]
30. Comparison of chemotherapy and hematopoietic stem cell transplantation pre and postterm DMFT scores: a preliminary study.
Ertas ET; Kurnaz F; Zorba YO; Kocyigit I; Sisman Y; Kaynar L; Sekerci AE; Ertas H; Cetin M
Niger J Clin Pract; 2014; 17(1):32-7. PubMed ID: 24326804
[TBL] [Abstract][Full Text] [Related]
31. Oral mucositis in pediatric patients undergoing hematopoietic stem cell transplantation: clinical outcomes in a context of specialized oral care using low-level laser therapy.
Eduardo Fde P; Bezinelli LM; de Carvalho DL; Lopes RM; Fernandes JF; Brumatti M; Vince CS; de Azambuja AM; Vogel C; Hamerschlak N; Correa L
Pediatr Transplant; 2015 May; 19(3):316-25. PubMed ID: 25677170
[TBL] [Abstract][Full Text] [Related]
32. Use of sodium hyaluronate and synthetic amino acid precursors of collagen for the symptomatic treatment of mucositis in patients undergoing haematopoietic stem cell transplants.
Ruggiero T; Pol R; Camisassa D; Arata V; Martino I; Giaccone L; Carossa S
J Biol Regul Homeost Agents; 2016; 30(3):889-894. PubMed ID: 27655517
[TBL] [Abstract][Full Text] [Related]
33. Role of the cyclooxygenase pathway in chemotherapy-induced oral mucositis: a pilot study.
Lalla RV; Pilbeam CC; Walsh SJ; Sonis ST; Keefe DM; Peterson DE
Support Care Cancer; 2010 Jan; 18(1):95-103. PubMed ID: 19404685
[TBL] [Abstract][Full Text] [Related]
34. Basic oral care for hematology-oncology patients and hematopoietic stem cell transplantation recipients: a position paper from the joint task force of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO) and the European Society for Blood and Marrow Transplantation (EBMT).
Elad S; Raber-Durlacher JE; Brennan MT; Saunders DP; Mank AP; Zadik Y; Quinn B; Epstein JB; Blijlevens NM; Waltimo T; Passweg JR; Correa ME; Dahllöf G; Garming-Legert KU; Logan RM; Potting CM; Shapira MY; Soga Y; Stringer J; Stokman MA; Vokurka S; Wallhult E; Yarom N; Jensen SB
Support Care Cancer; 2015 Jan; 23(1):223-36. PubMed ID: 25189149
[TBL] [Abstract][Full Text] [Related]
35. Professional oral health care reduces oral mucositis and febrile neutropenia in patients treated with allogeneic bone marrow transplantation.
Kashiwazaki H; Matsushita T; Sugita J; Shigematsu A; Kasashi K; Yamazaki Y; Kanehira T; Yamamoto S; Kondo T; Endo T; Tanaka J; Hashino S; Nishio M; Imamura M; Kitagawa Y; Inoue N
Support Care Cancer; 2012 Feb; 20(2):367-73. PubMed ID: 21328006
[TBL] [Abstract][Full Text] [Related]
36. Granulocyte transfusions could benefit patients with severe oral mucositis after allogeneic hematopoietic stem cell transplantation.
Berglund S; Watz E; Remberger M; Garming Legert K; Axdorph-Nygell U; Sundin M; Uhlin M; Mattsson J
Vox Sang; 2019 Oct; 114(7):769-777. PubMed ID: 31402469
[TBL] [Abstract][Full Text] [Related]
37. Efficacy of mouth rinse in preventing oral mucositis in patients receiving high-dose cytarabine for allogeneic hematopoietic stem cell transplantation.
Mori T; Hasegawa K; Okabe A; Tsujimura N; Kawata Y; Yashima T; Kobayashi N; Kondo S; Aisa Y; Kato J; Tsunoda K; Nagai T; Nakagawa T; Shigematsu N; Kubo A; Ikeda Y; Okamoto S
Int J Hematol; 2008 Dec; 88(5):583-587. PubMed ID: 18972188
[TBL] [Abstract][Full Text] [Related]
38. A comparison of oral mucositis in allogeneic hematopoietic stem cell transplantation between conventional and reduced-intensity regimens.
Kashiwazaki H; Matsushita T; Sugita J; Shigematsu A; Kasashi K; Yamazaki Y; Kanehira T; Kondo T; Endo T; Tanaka J; Hashino S; Nishio M; Imamura M; Kitagawa Y; Inoue N
Support Care Cancer; 2012 May; 20(5):933-9. PubMed ID: 21494780
[TBL] [Abstract][Full Text] [Related]
39. A prospective, double-blind phase II study evaluating the safety and efficacy of a topical histamine gel for the prophylaxis of oral mucositis in patients post hematopoietic stem cell transplantation.
Elad S; Ackerstein A; Bitan M; Shapira MY; Resnick I; Gesundheit B; Cohen Y; Diss O; Barak D; Dray L; Or R
Bone Marrow Transplant; 2006 Apr; 37(8):757-62. PubMed ID: 16518424
[TBL] [Abstract][Full Text] [Related]
40. Current Practice in Vitamin D Management in Allogeneic Hematopoietic Stem Cell Transplantation: A Survey by the Transplant Complications Working Party of the European Society for Blood and Marrow Transplantation.
Ros-Soto J; Snowden JA; Salooja N; Gilleece M; Parker A; Greenfield DM; Anthias C; Alfred A; Harrington A; Peczynski C; Peggs K; Madrigal A; Basak GW; Schoemans H;
Biol Blood Marrow Transplant; 2019 Oct; 25(10):2079-2085. PubMed ID: 31229642
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
